Platelet rich plasma clot releasate preconditioning induced PI3K/AKT/NFκB signaling enhances survival and regenerative function of rat bone marrow mesenchymal stem cells in hostile microenvironments

Stem Cells and Development

Volumn 22, Issue 24, 2013, Pages 3236-3251

  Peng, Yan ^a,b,c   Huang, Sha ^c   Wu, Yan ^d   Cheng, Biao ^a   Nie, Xiaohu ^b   Liu, Hongwei ^e   Ma, Kui ^c   Zhou, Jiping ^c   Gao, Dongyun ^c   Feng, Changjiang ^c   Yang, Siming ^c   Fu, Xiaobing ^c  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d MUDANJIANG MEDICAL UNIVERSITY   (China)

^e THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL REGENERATION; CELL STIMULATION; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIZATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PLATELET RICH CLOT RELEASATE; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURGICAL WOUND; THROMBOCYTE RICH PLASMA; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CULTURE MEDIA, CONDITIONED; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; RATS; SIGNAL TRANSDUCTION; STEM CELL NICHE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84889644839     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0064     Document Type: Article

References (79)

1. Caplan AI and D Correa. (2011). The MSC: An injury drugstore. Cell Stem Cell 9:11-15
2. Kim SW, H Han, GT Chae, SH Lee, S Bo, JH Yoon, YS Lee, KS Lee, HK Park and KS Kang. (2006). Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 24:1620-1626
3. Ishikane S, S Ohnishi, K Yamahara, M Sada, K Harada, K Mishima, K Iwasaki, M Fujiwara, S Kitamura, et al. (2008). Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 26:2625-2633
4. Dai W, SL Hale, BJ Martin, JQ Kuang, JS Dow, LE Wold and RA Kloner. (2005). Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short-And long-Term effects. Circulation 112:214-223
5. Amado LC, AP Saliaris, KH Schuleri, M St John, JS Xie, S Cattaneo, DJ Durand, T Fitton, JQ Kuang, et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102:11474-11479
6. Hatzistergos KE, H Quevedo, BN Oskouei, Q Hu, GS Feigenbaum, IS Margitich, R Mazhari, AJ Boyle, JP Zambrano, et al. (2010). Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107:913-922
7. Gnecchi M, Z Zhang, A Ni and VJ Dzau. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204-1219
8. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822
9. Menasche P. (2008). Current status and future prospects for cell transplantation to prevent congestive heart failure. Semin Thorac Cardiovasc Surg 20:131-137
10. Herberg S, X Shi, MH Johnson, MW Hamrick, CM Isales and WD Hill. (2013). Stromal cell-derived factor-1beta mediates cell survival through enhancing autophagy in bone marrowderived mesenchymal stem cells. PLoS One 8:e58207
11. Xu J, J Qian, X Xie, L Lin, Y Zou,M Fu, Z Huang, G Zhang, Y Su and J Ge. (2012). High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species. Int J Mol Sci 13:17104-17120
12. Savitz SI, DM Rosenbaum, JH Dinsmore, LR Wechsler and LR Caplan. (2002). Cell transplantation for stroke. Ann Neurol 52:266-275
13. Lo EH, T Dalkara and MA Moskowitz. (2003). Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399-415
14. Hodgetts SI, MW Beilharz, AA Scalzo and MD Grounds. (2000). Why do cultured transplanted myoblasts die in vivö DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1 + cells. Cell Transplant 9:489-502
15. Chacko SM, S Ahmed, K Selvendiran, ML Kuppusamy, M Khan and P Kuppusamy. (2010). Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol 299:C1562-1570
16. Busletta C, E Novo, L Valfre Di Bonzo, D Povero, C Paternostro, M Ievolella, K Mareschi, I Ferrero, S Cannito, et al. (2011). Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells. Stem Cells 29:952-963
17. Wisel S, M Khan, ML Kuppusamy, IK Mohan, SM Chacko, BK Rivera, BC Sun, K Hideg and P Kuppusamy. (2009). Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J Pharmacol Exp Ther 329:543-550
18. Lu C, D Chen, Z Zhang, F Fang, Y Wu, L Luo and Z Yin. (2007). Heat Shock Protein 90 regulates the stability of c-Jun in HEK293 Cells. Mol Cells 24:210-214
19. Chen D, J Pan, B Du and D Sun. (2005). Induction of the heat shock response in vivo inhibits NF-kappaB activity and protects murine liver from endotoxemia-induced injury. J Clin Immunol 25:452-461
20. Pasha Z, Y Wang, R Sheikh, D Zhang, T Zhao and M Ashraf. (2008). Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77:134-142
21. Bartunek J, JD Croissant,WWijns, S Gofflot, A de Lavareille, M Vanderheyden, Y Kaluzhny, N Mazouz, P Willemsen, et al. (2007). Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol 292:H1095-H1104
22. Ye L, H Haider, S Jiang, LH Ling, R Ge, PK Law and KE Sim. (2005). Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model. Eur J Heart Fail 7:945-952
23. Azarnoush K, A Maurel, L Sebbah, C Carrion, A Bissery, C Mandet, J Pouly, P Bruneval, AA Hagege and P Menasche. (2005). Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. J Thorac Cardiovasc Surg 130:173-179
24. Kofidis T, JL de Bruin, T Yamane, LB Balsam, DR Lebl, RJ Swijnenburg, M Tanaka, IL Weissman and CR Robbins. (2004). Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 22:1239-1245
25. Gnecchi M, H He, OD Liang, LG Melo, F Morello, H Mu, N Noiseux, L Zhang, RE Pratt, et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Aktmodified mesenchymal stem cells. Nat Med 11:367-368
26. Jiang S, H Haider, NM Idris, A Salim and M Ashraf. (2006). Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair.CircRes 99:776-784
27. Kutschka I, T Kofidis, IY Chen, G von Degenfeld, M Zwierzchoniewska, G Hoyt, T Arai, DR Lebl, SL Hendry, et al. (2006). Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation 114: I174-I180
28. Mei-Dan O, L Laver, M Nyska and G Mann. (2011). [Platelet rich plasma-A new biotechnology for treatment of sports injuries]. Harefuah 150:453-457, 490
29. Kim DH, YJ Je, CD Kim, YH Lee, YJ Seo, JH Lee and Y Lee. (2011). Can platelet-rich plasma be used for skin rejuvenatioñevaluation of effects of platelet-rich plasma on human dermal fibroblast. Ann Dermatol 23:424-431
30. Fukaya Y, M Kuroda, Y Aoyagi, S Asada, Y Kubota, Y Okamoto, T Nakayama, Y Saito, K Satoh and H Bujo. (2012). Platelet-rich plasma inhibits the apoptosis of highly adipogenic homogeneous preadipocytes in an in vitro culture system. Exp Mol Med 44:330-339
31. Kocaoemer A, S Kern, H Kluter and K Bieback. (2007). Human AB serum and thrombin-Activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25:1270-1278
32. Reinisch A, C Bartmann, E Rohde, K Schallmoser, V Bjelic-Radisic, G Lanzer, W Linkesch and D Strunk. (2007). Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med 2:371-382
33. Mishra A, P Tummala, A King, B Lee, M Kraus, V Tse and RC Jacobs. (2009). Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 15:431-435
34. Lin SS, R Landesberg, HS Chin, J Lin, SB Eisig and HH Lu. (2006). Controlled release of PRCR-derived growth factors promotes osteogenic differentiation of human mesenchymal stem cells. Conf Proc IEEE Eng Med Biol Soc 1:4358-4361
35. Eppley BL, WS Pietrzak and M Blanton. (2006). Platelet-rich plasma: A review of biology and applications in plastic surgery. Plast Reconstr Surg 118:147e-159e
36. Hu Z, SA Peel, SK Ho, et al. (2009). Platelet-rich plasma induces mRNA expression of VEGF and PDGF in rat bone marrow stromal cell differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:43-48
37. Bir SC, J Esaki, A Marui, K Yamahara, H Tsubota, T Ikeda and R Sakata. (2009). Angiogenic properties of sustained release platelet-rich plasma: Characterization in-vitro and in the ischemic hind limb of the mouse. J Vasc Surg 50:870-879, e872
38. Harichandan A and HJ Buhring. (2011). Prospective isolation of human MSC. Best Pract Res Clin Haematol 24:25-36
39. Wang HS, SC Hung, ST Peng, CC Huang, HM Wei, YJ Guo, YS Fu, MC Lai and CC Chen. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22:1330-1337
40. Haider H and M Ashraf. (2008). Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 45:554-566
41. Haynesworth SE, MA Baber and IA Caplan. (1996). Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1 alpha. J Cell Physiol 166:585-592
42. Kinnaird T, E Stabile, MS Burnett and SE Epstein. (2004). Bone-marrow-derived cells for enhancing collateral development: Mechanisms, animal data, and initial clinical experiences. Circ Res 95:354-363
43. Leedham SJ, M Brittan, SA McDonald and NA Wright. (2005). Intestinal stem cells. J Cell Mol Med 9:11-24
44. Togel F, Z Hu, K Weiss, J Isaac, C Lange and C Westenfelder. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differ-entiation-independent mechanisms. Am J Physiol Renal Physiol 289:F31-F42
45. Van Overstraeten-Schlogel N, Y Beguin and A Gothot. (2006). Role of stromal-derived factor-1 in the hematopoieticsupporting activity of human mesenchymal stem cells. Eur J Haematol 76:488-493
46. Miyahara Y, N Nagaya, M Kataoka, B Yanagawa, K Tanaka, H Hao, K Ishino, H Ishida, T Shimizu, et al. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12:459-465
47. Kinnaird T, E Stabile, MS Burnett, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685
48. Shake JG, PJ Gruber, WA Baumgartner, G Senechal, J Meyers, JM Redmond, MF Pittenger and BJ Martin. (2002). Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 73:1919-1925, discussion 1926
49. Bir SC, J Esaki, A Marui, H Sakaguchi, CG Kevil, T Ikeda, M Komeda, Y Tabata and R Sakata. (2011). Therapeutic treatment with sustained-release platelet-rich plasma restores blood perfusion by augmenting ischemia-induced angiogenesis and arteriogenesis in diabetic mice. J Vasc Res 48:195-205
50. Das H, JC George, M Joseph, M Das, N Abdulhameed, A Blitz, M Khan, R Sakthivel, HQ Mao, et al. (2009). Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One 4:e7325
51. Schlessinger J. (2000). Cell signaling by receptor tyrosine kinases. Cell 103:211-225
52. Stratman AN, AE Schwindt, KM Malotte and GE Davis. (2010). Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 116:4720-4730
53. Lindahl P, BR Johansson, P Leveen and C Betsholtz. (1997). Pericyte loss and microaneurysm formation in PDGF-Bdeficient mice. Science 277:242-245
54. Wang H, Y Yin, W Li, X Zhao, Y Yu, J Zhu, Z Qin, Q Wang, K Wang, et al. (2012). Over-expression of PDGFR-beta promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathway. PLoS One 7:e30503
55. Floege J, F Eitner and CE Alpers. (2008). A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 19:12-23
56. Casella I, T Feccia, C Chelucci, P Samoggia, G Castelli, R Guerriero, I Parolini, E Petrucci, E Pelosi, et al. (2003). Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. Blood 101:1316-1323
57. Gerber HP, AK Malik, GP Solar, D Sherman, XH Liang, G Meng, K Hong, JC Marsters and N Ferrara. (2002). VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417:954-958
58. Furumatsu T, ZN Shen, A Kawai, K Nishida, H Manabe, T Oohashi, H Inoue and Y Ninomiya. (2003). Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. J Biochem 133:633-639
59. Ball SG, CA Shuttleworth and CM Kielty. (2007). Vascular endothelial growth factor can signal through plateletderived growth factor receptors. J Cell Biol 177:489-500
60. Senftleben U and M Karin. (2002). The IKK/NF-kappa B pathway. Criti Care Med 30:S18-S26
61. Herrmann JL, BR Weil, AM Abarbanell, Y Wang, JA Poynter, MC Manukyan and DR Meldrum. (2011). IL-6 and TGF-Alpha costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms. Shock 35:512-516
62. Tallquist M and A Kazlauskas. (2004). PDGF signaling in cells and mice. Cytokine Growth Factor Rev 15:205-213
63. Hung SC, RR Pochampally, SC Chen, SC Hsu and DJ Prockop. (2007). Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25:2363-2370
64. Brunet A, A Bonni, MJ Zigmond, MZ Lin, P Juo, LS Hu, MJ Anderson, KC Arden, J Blenis and ME Greenberg. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
65. Franke TF, DR Kaplan and LC Cantley. (1997). PI3K: Downstream AKTion blocks apoptosis. Cell 88:435-437
66. Datta SR, A Brunet and ME Greenberg. (1999). Cellular survival: A play in three Akts. Genes Dev 13:2905-2927
67. Bekhite MM, A Finkensieper, S Binas, J Muller, R Wetzker, HR Figulla, H Sauer and M Wartenberg. (2011). VEGFmediated PI3K class IA and PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells. J Cell Sci 124:1819-1830
68. Ando H, K Nakanishi, M Shibata, K Hasegawa, K Yao and H Miyaji. (2006). Benidipine, a dihydropyridine-Ca2 + channel blocker, increases the endothelial differentiation of endothelial progenitor cells in vitro. Hypertens Res 29:1047-1054
69. Chu L, H Hao, M Luo, Y Huang, Z Chen, T Lu, X Zhao, CM Verfaillie, JL Zweier and Z Liu. (2011). Ox-LDL modifies the behaviour of bone marrow stem cells and impairs their endothelial differentiation via inhibition of Akt phosphorylation. J Cell Mol Med 15:423-432
70. Hoffmann A, A Levchenko, ML Scott and D Baltimore. (2002). The IkappaB-NF-kappaB signaling module: Temporal control and selective gene activation. Science 298:1241-1245
71. Kuhnel F, L Zender, Y Paul, MK Tietze, C Trautwein, M Manns and S Kubicka. (2000). NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem 275:6421-6427
72. Misra A, SB Haudek, P Knuefermann, JG Vallejo, ZJ Chen, LH Michael, N Sivasubramanian, EN Olson, ML Entman and LD Mann. (2003). Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 108:3075-3078
73. Pahl HL. (1999). Activators and target genes of Rel/NFkappaB transcription factors. Oncogene 18:6853-6866
74. Karin M and A Lin. (2002). NF-kappaB at the crossroads of life and death. Nat Immunol 3:221-227
75. Becker C, MC Fantini, C Schramm, HA Lehr, S Wirtz, A Nikolaev, J Burg, S Strand, R Kiesslich, et al. (2004). TGFbeta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21:491-501
76. Gross A, J Jockel, MC Wei and JS Korsmeyer. (1998). Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 17:3878-3885
77. Yang E and SJ Korsmeyer. (1996). Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88: 386-401
78. Ashkenazi A and VM Dixit. (1998). Death receptors: Signaling and modulation. Science 281:1305-1308
79. Nishikawa S, T Tatsumi, J Shiraishi, S Matsunaga, M Takeda, A Mano, M Kobara, N Keira, M Okigaki, et al. (2006). Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis. J Mol Cell Cardiol 40:510-519